Wall Street Access Asset Management »

Blueprint Medicines Corporation shares owned by Wall Street Access Asset Management

Quarter-by-quarter ownership of Blueprint Medicines Corporation shares owned by Wall Street Access Asset Management from 13F filings

Historical chart of Wall Street Access Asset Management investment in Blueprint Medicines Corporation

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines Corporation held by Wall Street Access Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines Corporation by Wall Street Access Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $0 300 0.00

More positions owned by Wall Street Access Asset Management

iShares Trust S&P Equities (IVV)
Berkshire Hathaway Inc Del Cl A Common Stock (BRK.A)
Invesco S&P 500 Equal Weight ETF Equities (RSP)
Microsoft Corp Equities (MSFT)
Apple Equities (AAPL)
Alphabet Inc Class C Equities (GOOG)
Berkshire Hathaway Inc B Equities (BRK.B)
Amazon Equities (AMZN)
Tweedy Browne Global Value Fund Equities (TBGVX)
Dimensional US Small Cap ETF Equities (DFAS)
American Balanced Fund Class F2 Mutual Fund (AMBFX)
Edgewood Growth Fund Instl Cl Equities (EGFIX)
Meta Platforms Inc Class A Equities (META)
T. Rowe Price Capital Appreciation Fund Class I Mutual Fund (TRAIX)
Alphabet Inc Class A Equities (GOOGL)

View all positions for Wall Street Access Asset Management

Top funds holding Blueprint Medicines Corporation

Flagship Wealth Advisors
Wall Street Access Asset Management
Massmutual Trust
Private Trust Co Na

View all funds holding Blueprint Medicines Corporation